Zydus Settles Mirabegron Patent Dispute With Astellas for USD 120 Million
New Delhi: Zydus Lifesciences has entered into a settlement agreement with Astellas Pharma Inc. to resolve ongoing patent litigation in the United States related to Myrbetriq (Mirabegron).The company informed the…